SynthesisThe Journal of international medical research2022

Efficacy and safety of FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy: A systematic review and meta-analysis.

Wenjie Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.